CONTENT.NEJM.ORG : content.nejm.org - 9 in TOP 100 MEDICAL SITES. Rating: 371000.

Description: The New England Journal of Medicine (NEJM) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.

Most popular searches: content.enjm.org, content.nejmo.rg, contnt.nejm.org, content.nejm.org, content.ejm.org, ocntent.nejm.org, medicine journal, content.nejm.rg, nejm.org, clinical research, content.nejmorg, New England Journal of Medicine, online medical journal, clinical medicine, cotnent.nejm.org, contet.nejm.org, New England Journal, conten.nejm.org, content.nej.morg, content.nej.org, ontent.nejm.org, contnet.nejm.org, content.nejm.com, contentnejm.org, contetn.nejm.org, internal medicine, contentn.ejm.org, content.njm.org, New England Journal of Medicine, general medicine, content.nem.org, cnotent.nejm.org, medical information, medical research, clinical practice, cotent.nejm.org, content.nemj.org, content.nejm.og, content.nejm.rog, The New England, medicine, NEJM, conent.nejm.org, medical journal, conten.tnejm.org, content.njem.org, content.nejm.or, conetnt.nejm.org, content.nejm.ogr, cntent.nejm.org, new england medical journal

FDA Panel Backs Cancer Vaccines
An FDA panel backed a Glaxo vaccine designed to protect against cervical cancer in women and approved expansion of the use of Merck's competitor vaccine Gardasil in males.
online.barrons.com

A Mixed Bag for Traders and Investors in Healthcare
As futures for the Dow Jones industrial average, the S&P 500 and the Nasdaq 100 are all pointing to a higher opening on Monday, it's important to note that we are starting a busy week of earnings, and that could be a mixed bag for traders and investors. Last week, the five day trading stretch ended with some drops in stock prices among some familiar names. Let's begin with Acorda Therapeutics (NASDAQ:ACOR) whose shares dropped -21.36%, after the U.S. Food and Drug Administration (FDA) posted on its website briefing documents for the Peripheral and Central Nervous System Drugs Advisory Committee meeting to review Acorda’s New Drug Application (NDA) for Fampridine-SR for the proposed indication of improvement of walking ability in people with multiple sclerosis (MS).Complete Story »
seekingalpha.com

Public Option Creates Barriers for Bill
Sen. Harry Reid's push for a public option is creating new obstacles for health-care legislation, while Sen. Joe Lieberman said he would vote to block passage of the bill in its current form.
online.barrons.com

LabCorp Receives Notification from the Holders of the Minority Interest in the Company's Ontario, Canada Joint Venture (Business Wire)
BURLINGTON, N.C.----Laboratory Corporation of AmericaÂ® Holdings announced today that it has received notification from the holders of the minority interest in the Company's Ontario, Canada joint venture, that they intend to put their remaining partnership units to the Company in accordance with the terms of the joint ventureâ€™s partnership agreement.
us.rd.yahoo.com

PAREXEL International Corporation F2Q10 (Qtr End 12/31/09) Earnings Call Transcript
PAREXEL International Corporation (PRXL)F2Q10 (Qtr End 12/31/09) Earnings Call TranscriptComplete Story »
seekingalpha.com